WAVE Life Sciences Ltd (WVE.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|58||2012||Independent Chairman of the Board|
|43||2013||President, Chief Executive Officer, Director|
|47||2016||Chief Financial Officer|
|39||2017||Senior Vice President, Corporate Development & Portfolio Management|
|56||2014||Senior Vice President, Head of Drug Discovery|
- BRIEF-Wave Life Sciences And Takeda Form Strategic Collaboration To Advance Therapies For Central Nervous System Disorders
- BRIEF-Wave Life Sciences Reports Data From Preclinical Studies Testing WVE-3972-01
- BRIEF-Wave Life Sciences Q3 net loss of $26.1 million
- BRIEF-Wave Life Sciences opens new 90,000 square foot manufacturing facility
- BRIEF-Teva pharmaceutical reports 5 pct stake in Wave Life Sciences as of Aug 30, 2017 versus 9 percent stake as of Nov 16, 2015